Neuren Pharmaceuticals LimitedASX: NEU

Neuren initiates manufacture of NNZ-2591 for Phase 2 trials

Sep 22, 2020 at 4:06 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment